TRILACICLIB DIHYDROCHLORIDE | N214200 | PHARMACOSMOS AS
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D.N.J. | 2025-05-07 | Terminated 2026-01-06 | — | |
PHARMACOSMOS A/S et al v. DR. REDDY'S LABORATORIES, INC. et al 13 patentsANDA 220230trilaciclib | D.N.J. | 2025-05-07 | Terminated 2026-01-06 | — |
PHARMACOSMOS A/S et al v. TEVA PHARMACEUTICALS, INC. et al 2 patentsANDA 219413trilaciclib | D.N.J. | 2025-04-24 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8598186 | Dec 30, 2034 | — | Yes | Yes | — | — |
| 8598197 | Oct 25, 2031 | — | Yes | Yes | — | — |
| 9487530 | Mar 14, 2034 | — | — | — | — | |
| 9957276 | Oct 25, 2031 | — | Yes | — | — | — |
| 10085992 | Mar 14, 2034 | — | — | — | — | |
| 10189849 | Oct 25, 2031 | — | Yes | — | — | — |
| 10189850 | Oct 25, 2031 | — | — | Yes | — | — |
| 10927120 | Oct 25, 2031 | — | — | Yes | — | — |
| 10966984 | Mar 14, 2034 | — | — | — | — | |
| 11040042 | Oct 25, 2031 | — | — | Yes | — | — |
| 11529352 | Jul 23, 2039 | — | — | — | — | |
| 11717523 | Mar 14, 2034 | — | — | — | — | |
| 12168666 | Nov 13, 2040 | — | Yes | Yes | — | — |
| 12527798 | Dec 5, 2037 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| NCE | Feb 12, 2026 | Expired |